the_worm06

Thoughts, Comments and Research on Publicly Traded Companies and Internet Stock Message Boards

Wednesday, May 14, 2008

[LBWR]: CEO Dexter Morris' representative states that Labwire, Inc.'s Securities Counsel, David B. Stocker, continued from 2005 until mid-2007

.
Promoter Creede Bighorns ("Cris"), a representative of LBWR CEO Dexter Morris, reported on the message boards that LBWR Securities Counsel, David B. Stocker, continued as the company's Securities Counsel until mid-2007.

Some background on attorney David B. Stocker is shown in the link below, including the June and November 2007 complaints filed by the SEC charging him and several co-conspirators with securities fraud in the illegal sale of un-registered securities. Coincidentally, LBWR was involved with several private placements during 2005-7. Since Stocker continued as LBWR's Securities Counsel during this period of time, does this mean that he was also involved in the private placements of the Company for the period 2005-7?


http://snipurl.com/28vfw




Here is Promoter Creede Bighorns' report from his convesation with LBWR CEO Dexter Morris:

http://siliconinvestor.advfn.com/readmsg.aspx?msgid=24586149

To: rrufff who wrote (624)
5/13/2008 8:29:59 PM
From: Creede Bighorns

1 Recommendation Read Replies (1)
845 of 851

Hey rrufff,

I was asked to called Dexter today, so I did. Here's the bullet points.

re David Stocker - When I questioned Dexter about David Stocker, and the allegations against him, Dexter's reply was as follows: "David did a great job for us, and I have nothing negative to say about him.". He then went on to say that actually David has not filed anything for Labwire or Dexter in about 3 years. I then asked him when he was released as Labwire's attorney, and he said that actually David called one day in the middle of last year and simply resigned. David cited health reasons for his retirement.....





_____________________________________________

2 Comments:

Anonymous Anonymous said...

yawn.

210

+20

GB-ND
c. Bighorns

8:14 PM  
Anonymous Anonymous said...

Labwire Signs Alliance Agreement With USIS
Thursday May 15, 9:00 am ET


HOUSTON, TX--(MARKET WIRE)--May 15, 2008 -- Labwire, Inc. (Other OTC:LBWR.PK - News), a leading provider of employee screening solutions, security, and compliance surveillance services, is pleased to report that on April 30, 2008 Labwire signed an Alliance Agreement with USIS, a large national commercial services group. Under the terms of the Alliance Agreement, Labwire will perform drug/alcohol testing services and pre-employment background screening products and services for certain USIS clients: in turn, USIS will offer their products for sale by Labwire to its clients. The agreement is for an initial term of two (2) years and provides for both firms to pay referral fees based on a percent of business delivered. The initial clients referred by USIS will begin transitioning to Labwire on June 2, 2008 and will continue through year's end and will include several large operating units in commercial transportation industries.
ADVERTISEMENT


"Mr. Morris and the sales team are to be congratulated for securing this substantial relationship agreement," stated Marlin Williford, CFO. "As this agreement is implemented, it should provide good revenue growth for the 3rd and 4th quarters of this year."

Dexter Morris, Labwire Chairman and CEO, offers the following business insight: "We are excited about our technology gaining the acceptance of a company such as USIS. We see this as a first step in expanding our client base through alliances as well as direct sales and acquisition opportunities. Labwire will continue to seek this type of alliance agreement with other major companies offering various services. We believe that these alliance arrangements will allow Labwire to grow more rapidly utilizing the strength and effectiveness of its operating platform to grow its revenue at a faster rate than conventional sales would allow."

USIS is a worldwide provider of background investigations, pre-employment/drug screenings, insurance information services, due diligence and risk management assessment, and security and related professional services to businesses, federal agencies, and institutions. Headquartered in Falls Church, Va., USIS has more than 7,000 employees supporting business operations in all 50 states, U.S. territories, and overseas. For more information, please visit www.usis.com.

Labwire, Inc., headquartered in Houston, TX, provides secure and compliant employee drug screening and background checking services to Fortune 500 corporations via the Labwire(TM) Platform. Labwire(TM) is a proprietary, web-based application that streamlines the complex regulatory and record management activities associated with employee screening, delivering accurate timely results while eliminating service calls and paper trails. This comprehensive solution to managing employee screening services is the most efficient and cost-effective platform in the industry. For more information see 8-k filings.

Safe Harbor Provisions:

Certain oral statements made by management from time to time and certain statements contained in press releases and periodic reports issued by Labwire, Inc., (the "Company"), as well as those contained herein, that are not historical facts are "forward-looking statements" within the meaning of Section 21E of the Securities and Exchange Act of 1934 and, because such statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements, including those in Management's Discussion and Analysis, are statements regarding the intent, belief or current expectations, estimates or projections of the Company, its Directors or its Officers about the Company and the industry in which it operates, and are based on assumptions made by management. Forward-looking statements include without limitation statements regarding: (a) the Company's strategies regarding growth and business expansion, including future acquisitions; (b) the Company's financing plans; (c) trends affecting the Company's financial condition or results of operations; (d) the Company's ability to continue to control costs and to meet its liquidity and other financing needs; (e) the declaration and payment of dividends; and (f) the Company's ability to respond to changes in customer demand and regulations. Although the Company believes that its expectations are based on reasonable assumptions, it can give no assurance that the anticipated results will occur. When issued in this report, the words "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," and similar expressions are generally intended to identify forward-looking statements.

Important factors that could cause the actual results to differ materially from those in the forward-looking statements include, among other items, (i) changes in the regulatory and general economic environment; (ii) conditions in the capital markets, including the interest rate environment and the availability of capital; (iii) changes in the competitive marketplace that could affect the Company's revenue and/or cost and expenses, such as increased competition, lack of qualified marketing, management or other personnel, and increased labor and inventory costs; (iv) changes in technology or customer requirements, which could render the Company's technologies noncompetitive or obsolete; (v) new product introductions, product sales mix and the geographic mix of sales.

The Company disclaims any intention or obligation to update or revise forward-looking statements, whether as a result of new information, future events or otherwise. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements which are not historical facts contained in this advertisement are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, governmental approval processes, the impact of competitive products or pricing, technological changes, and the effect of economic conditions.



Contact:
Investor and Public Relations Contact:
Marlin R. Williford Jr.
email: mwilliford@capnetrisk.com
Phone: (832) 487-7803

GB-ND
creede

9:59 AM  

Post a Comment

<< Home